Here we show that a heterologous prime-boost vaccination regime of DNA either intramuscularly or epidermally, followed by intradermal recombinant modified vaccinia virus Ankara (MVA), induces high ...

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

The modified vaccinia virus Ankara (MVA)-based live attenuated monkeypox vaccine, independently developed by Shanghai Institute of Biological Products Co (SIBP) under China National Pharmaceutical ...

more effectively limits symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus when compared to a currently licensed modified vaccinia Ankara (MVA ...

TG4001 is a recombinant vaccine highly attenuated Modified Vaccinia virus Ankara (MVA) vector whose genome has been modified with the insertion of transgenes coding for three proteins, the HPV E6 ...

A virus related to variola called monkeypox virus recently ... These groups are also planning to evaluate a new generation of smallpox vaccines (Modified Vaccinia Ankara and LC16m8 ) that produce ...

has issued a Notice of Allowance for Patent Application No. 18/394,555 titled "Replication-Deficient Modified Vaccinia Ankara (MVA) Expressing Marburg Virus Glycoprotein (GP) and Matrix Protein ...

Kenya will soon launch its first Mpox vaccination campaign in 13 counties to prevent transmission of the virus.This follows the arrival of 10,700 doses of the Modified Vaccinia Ankara-Bavarian ...

About the GeoVax MVA Platform GeoVax’s vaccine platform utilizes modified vaccinia Ankara (MVA), a large virus capable of carrying several vaccine antigens, that expresses proteins that assemble into ...